Afișare rezultate

SM ISO690:2012

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19

Singh Dave123, Boguş Maxim4, Moskalenko Valentyn5, Noi Autori

3 Brovary multidisciplinary clinical hospital, 4 Timofei Moșneaga Republican Clinical Hospital,

European Respiratory Journal

Nr. / 2021 / ISSN 0903-1936 /ISSNe 1399-3003

Disponibil online 19 July, 2023. Descarcări-0. Vizualizări-178

-----------------------------------------------------------------------------------------------------------------------------------

Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis

Conradie Francesca M.1, Bagdasaryan Tatevik R.2, Borisov S.3, Tudor Elena4, Noi Autori

2 Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences, 3 The Moscow Research and Clinical Center for Tuberculosis Control of the Moscow Government Department of Health, 4 Institute of Phtysiopneumology „Chiril Draganiuc”

New England Journal of Medicine

Nr. / 2022 / ISSN 0028-4793

Disponibil online 19 June, 2023. Descarcări-4. Vizualizări-280

-----------------------------------------------------------------------------------------------------------------------------------

The risk of error in medication prescribing – legal and institutional gaps

Gramma Rodica, Pădure Andrei

”Nicolae Testemițanu” State University of Medicine and Pharmacy

Romanian Journal of Legal Medicine

Nr. / 2023 / ISSN 1221-8618 /ISSNe 1844-8585

Disponibil online 25 November, 2023. Descarcări-0. Vizualizări-127

-----------------------------------------------------------------------------------------------------------------------------------

10203040501005001000